Neil J. Greening

Jan 16, 2025 | publications.ersnet.org | Enya Daynes |Rachael Evans |Neil J. Greening |Nicolette C. Bishop

Original Research Article Open access Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation ArticleInfo & Metrics This is a PDF-only article. Please click on the PDF link above to read it.

Apr 8, 2024 | nature.com | Claudia Efstathiou |Shona C Moore |Jose Nunag |Amisha Singapuri |Marco Sereno |Linzy Houchen-Wolloff | +12 more

AbstractOne in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged symptoms termed long coronavirus disease (COVID), yet disease phenotypes and mechanisms are poorly understood1. Here we profiled 368 plasma proteins in 657 participants ≥3 months following hospitalization. Of these, 426 had at least one long COVID symptom and 233 had fully recovered. Elevated markers of myeloid inflammation and complement activation were associated with long COVID.

Dec 20, 2023 | err.ersjournals.com | Sally J Singh |Betty Raman |Neil J. Greening |Rachael Evans

BackgroundCoronavirus disease 2019 (COVID-19) caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing global health emergency and was identified as a global pandemic by the World Health Organization in February 2020. COVID-19 can lead to a number of persisting and disabling symptoms. Significant symptoms include breathlessness, fatigue and muscle pain, reducing an individual's ability to engage in activities of daily living for months and often beyond a year [1, 2].

Aug 31, 2023 | nature.com | Maxime Taquet |Alex Horsley |Amisha Singapuri |Marco Sereno |Linzy Houchen-Wolloff |Neil J. Greening | +5 more

AbstractPost-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective and subjective components. They are common and debilitating, and can affect the ability to work, yet their biological underpinnings remain unknown. In this prospective cohort study of 1,837 adults hospitalized with COVID-19, we identified two distinct biomarker profiles measured during the acute admission, which predict cognitive outcomes 6 and 12 months after COVID-19.